Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|January 7, 2009
Quinolone resistance in Neisseria gonorrhoeae: rapid genotyping of quinolone resistance-determining regions in gyrA and parC genes by melting curve analysis predicts susceptibilityFrédérique Vernel-Pauillac, Tiffany R Hogan, John W Tapsall, et al.
Communicable Diseases Intelligence Quarterly Report|August 27, 2005
Evaluation of the Australian Gonococcal Surveillance ProgrammeGina Samaan, Paul W Roche, Jane E Greig, et al.
Bulletin of the World Health Organization|January 18, 2005
The antimicrobial resistance containment and surveillance approach--a public health toolGunnar S Simonsen, John W Tapsall, Benedetta Allegranzi, et al.
Journal of Clinical Microbiology|April 7, 2006
Dynamics of appearance and expansion of a prolyliminopeptidase- negative subtype among Neisseria gonorrhoeae isolates collected in Sydney, Australia, from 2002 to 2005E Athena Limnios, Nhu-Lan Nguyen, Sanghamitra Ray, et al.
Communicable Diseases Intelligence Quarterly Report|January 29, 2003
Refining the public health response to primary meningococcal conjunctivitisRoslyn G Poulos, Elizabeth J Smedley, Mark J Ferson, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2007
Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxoneDavid M Whiley, E Athena Limnios, Sanghamitra Ray, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|April 11, 2003
Late-onset and recurrent neonatal Group B streptococcal disease associated with breast-milk transmissionMichael Kotiw, Gwang W Zhang, Grant Daggard, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2010
Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strainsDavid M Whiley, Susanne Jacobsson, John W Tapsall, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?Magnus Unemo, Daniel Golparian, Athena Limnios, et al.
Pathology|October 1, 2005
Molecular tests can allow confirmation of invasive meningococcal disease when isolates yield atypical maltose, glucose or gamma-glutamyl peptidase test resultsAngelo Zaia, Julia M Griffith, Tiffany R Hogan, et al.
Pageof 3